|1.||Lethaby, A: 8 articles (01/2008 - 01/2000)|
|2.||Farkas, Henriette: 6 articles (01/2014 - 04/2005)|
|3.||Varga, Lilian: 6 articles (01/2014 - 04/2005)|
|4.||Bork, Konrad: 6 articles (03/2011 - 05/2002)|
|5.||Füst, George: 5 articles (03/2011 - 04/2005)|
|6.||Duckitt, K: 5 articles (01/2007 - 01/2000)|
|7.||Farquhar, C: 5 articles (01/2007 - 01/2000)|
|8.||Augood, C: 5 articles (01/2007 - 01/2000)|
|9.||Hughes, E: 5 articles (01/2007 - 01/2000)|
|10.||Vandekerckhove, P: 5 articles (01/2007 - 01/2000)|
03/01/1989 - "Although the high pretreatment level of serum CA 125 decreased after danazol treatment of 400 mg/day to within the normal limits, usually within 4 to 12 weeks, laparoscopic examinations indicated that most of the endometriosis cases were not cured until 12-16 weeks of danazol treatment."
01/01/1979 - "Based on "second look" pelviscopic control in 438 cases of pelvic endometrosis, additional hormonal antigonadotrophin therapy with danazol represents the most effective treatment for endometriosis. "
07/01/1976 - "Nineteen of the 40 patients in the study had a secondary diagnosis of pelvic endometriosis confirmed histologically, and all these patients showed a marked improvement of symptoms during the Danazol treatment. "
10/15/1981 - "The results of large clinical studies suggest that danazol treatment produces significant improvement in the symptoms, signs, and laparoscopic findings of endometriosis. "
11/01/1990 - "This review suggests that endometrioma of the intestine requires a high index of suspicion for diagnosis and that danazol does not appear to be effective treatment for these patients."
03/01/2014 - "Danazol treatment is highly effective in relieving pain and decreasing CA-125 concentrations in the plasma. "
06/01/1982 - " The use of a newsteroidal agent, danazol, on a 3-6 month trial of 100-400 mg/day will eliminate pain and nodosities in some 69% of women and in another 30% the signs and symptoms will be diminished."
01/01/1979 - "The preliminary results of a double-blind randomized cross-over trial of danazol versus placebo in patients with severe cyclical breast pain are reported. "
01/01/2012 - "For lumbosacral pain, rectal discomfort, or vaginal nodules tenderness, there was no significant difference between CHM and danazol. "
06/01/2011 - "In Danazol group 69.44% women achieved reduction in pain score to ≤ 3 (p = 0.001). "
01/01/1988 - "A 24-year-old woman, having familial hereditary angioneurotic edema (HAE) treated with danazol, developed an anti-Ro-positive lupus featured by a mild erythematous eruption that seemed initially to decrease and then worsened under danazol, and dramatically improved after danazol was withdrawn. "
05/01/1980 - "Danazol is an effective agent for the prophylaxis of the recurrent attacks of mucocutaneous and visceral swelling which occur in patients with hereditary angioedema (HAE). "
04/01/1979 - "Danazol, an attentuated androgen, has been suggested as an effective agent for the prophylaxis of attacks of hereditary angioedema. "
04/01/1999 - "This study evaluated the efficacy of short-term danazol prophylaxis in hereditary angioedema patients undergoing maxillofacial or dental procedures. "
03/01/2011 - "Long-term efficacy of danazol treatment in hereditary angioedema."
|4.||Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
08/01/1987 - "Although danazol is effective in the treatment of idiopathic thrombocytopenic purpura, its long-term safety and optimal dosage are not well established. "
03/01/1987 - "Thus, danazol appears to be an effective immune modulator, correcting the abnormality of T-cell subsets seen in autoimmune thrombocytopenia by increasing the percentage of Thi lymphocytes."
06/01/1992 - "Danazol therapy in idiopathic thrombocytopenic purpura: the efficacy of low-medium dose therapy."
11/01/1989 - "Long-term danazol therapy in autoimmune thrombocytopenia: unmaintained remission and age-dependent response in women."
10/01/2008 - "[Danazol - effective second line therapy in idiopathic thrombocytopenic purpura in children. "
05/01/2002 - "The danazol treatment relieved the symptoms of angioedema and increased the C1 INH activity and concentration with the normalization of CH50, C1q and C4 levels. "
04/01/1990 - "She responded well to danazol and had no further attacks of angioedema."
05/01/2012 - "Although the anabolic steroid, danazol, is useful in increasing the concentration of C4 and reducing the episodes of angioedema in HAE and AAE, it has expected adverse effects. "
11/01/2003 - "The angioedema was controlled with Danazol and Stanasol. "
06/01/2003 - "The angioedema was controlled with Danazol and Stanasol. "
|1.||Gonadotropin-Releasing Hormone (GnRH)
|6.||Inosine Triphosphate (ITP)
|2.||Intrauterine Devices (Intrauterine Device)
|3.||Drug Therapy (Chemotherapy)